1. Home
  2. LEGN vs BRX Comparison

LEGN vs BRX Comparison

Compare LEGN & BRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • BRX
  • Stock Information
  • Founded
  • LEGN 2014
  • BRX 2011
  • Country
  • LEGN United States
  • BRX United States
  • Employees
  • LEGN N/A
  • BRX N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • BRX Real Estate Investment Trusts
  • Sector
  • LEGN Health Care
  • BRX Real Estate
  • Exchange
  • LEGN Nasdaq
  • BRX Nasdaq
  • Market Cap
  • LEGN 7.0B
  • BRX 8.0B
  • IPO Year
  • LEGN 2020
  • BRX 2013
  • Fundamental
  • Price
  • LEGN $27.78
  • BRX $26.59
  • Analyst Decision
  • LEGN Strong Buy
  • BRX Buy
  • Analyst Count
  • LEGN 13
  • BRX 13
  • Target Price
  • LEGN $75.67
  • BRX $30.40
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • BRX 2.2M
  • Earning Date
  • LEGN 05-13-2025
  • BRX 04-28-2025
  • Dividend Yield
  • LEGN N/A
  • BRX 4.35%
  • EPS Growth
  • LEGN N/A
  • BRX 12.84
  • EPS
  • LEGN N/A
  • BRX 1.05
  • Revenue
  • LEGN $728,303,000.00
  • BRX $1,302,325,000.00
  • Revenue This Year
  • LEGN $65.96
  • BRX $5.60
  • Revenue Next Year
  • LEGN $52.55
  • BRX $4.35
  • P/E Ratio
  • LEGN N/A
  • BRX $25.20
  • Revenue Growth
  • LEGN 112.46
  • BRX 3.87
  • 52 Week Low
  • LEGN $29.27
  • BRX $21.32
  • 52 Week High
  • LEGN $60.87
  • BRX $30.67
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.61
  • BRX 59.33
  • Support Level
  • LEGN $30.25
  • BRX $25.39
  • Resistance Level
  • LEGN $33.30
  • BRX $26.49
  • Average True Range (ATR)
  • LEGN 1.78
  • BRX 0.58
  • MACD
  • LEGN -0.57
  • BRX 0.14
  • Stochastic Oscillator
  • LEGN 5.19
  • BRX 99.77

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About BRX Brixmor Property Group Inc.

Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.

Share on Social Networks: